Skip to main content

Peer Review reports

From: Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

Original Submission
16 Mar 2020 Submitted Original manuscript
7 Apr 2020 Reviewed Reviewer Report - Ekta Khattar
19 Apr 2020 Reviewed Reviewer Report - Nootan Pandey
24 Apr 2020 Author responded Author comments - Masashi Sawada
29 Apr 2020 Author responded Author comments - Masashi Sawada
Resubmission - Version 2
24 Apr 2020 Submitted Manuscript version 2
7 May 2020 Author responded Author comments - Masashi Sawada
Resubmission - Version 3
7 May 2020 Submitted Manuscript version 3
Publishing
10 May 2020 Editorially accepted
20 May 2020 Article published 10.1186/s12885-020-06945-8

You can find further information about peer review here.

Back to article page